Abstract | OBJECTIVES: PATIENTS AND MEASUREMENTS: RESULTS: Plasma 19-OH-A-dione concentrations in control subjects and patients with normal and high renin essential hypertension were 115 +/- 46 (mean +/- SD), 112 +/- 49 and 201 +/- 79 pmol/l, respectively. Patients with high renin essential hypertension showed significantly higher 19-OH-A-dione concentrations than did control subjects. The evaluation of the correlation between plasma 19-OH-A-dione concentrations and plasma renin activity revealed that plasma 19-OH-A-dione concentrations in hypertensive subjects rose gradually with an increase in plasma renin activity. Therefore, a significant correlation was found between plasma renin activity and plasma 19-OH-A-dione (r = 0.586, P < 0.001). In contrast, in control subjects, no significant correlation was found between plasma renin activity and plasma 19-OH-A-dione (r = 0.059, P > 0.05). CONCLUSIONS: The secretion of 19-OH-A-dione from the adrenal cortex is under the control of the renin-angiotensin system in hypertensives but not in normotensives.
|
Authors | H Sekihara, K Yonemitsu, Y Yazaki |
Journal | Clinical endocrinology
(Clin Endocrinol (Oxf))
Vol. 39
Issue 5
Pg. 557-60
(Nov 1993)
ISSN: 0300-0664 [Print] England |
PMID | 8252745
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Androstenedione
- 19-hydroxy-4-androstene-3,17-dione
- Renin
|
Topics |
- Adult
- Androstenedione
(analogs & derivatives, blood)
- Humans
- Hypertension
(blood)
- Male
- Middle Aged
- Radioimmunoassay
- Renin
(blood)
|